Lantern Pharma Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q2 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary: Lantern Pharma Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q2 2022 to Q3 2024.
Lantern Pharma Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2024 was -0.42 USD/shares, a 44.8% decline year-over-year.
Lantern Pharma Inc. Earnings Per Share, Diluted for the twelve months ending September 30, 2024 was -1.77 USD/shares.
Lantern Pharma Inc. annual Earnings Per Share, Diluted for 2023 was -1.47 USD/shares, a 12.2% decline from 2022.

Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)

Earnings Per Share, Diluted, Quarterly (USD/shares)

Earnings Per Share, Diluted, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$2	$0	$0	-44.8%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	-$2	$0	$0	-4.55%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	-$2	-$1	$0	-41.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$1	$0			Oct 1, 2023	Dec 31, 2023	10-K	2024-03-18
Q3 2023		$0	$0	-38.1%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-07
Q2 2023		$0	$0	-7.32%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023		$0			Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q3 2022		$0			Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022		$0			Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.